正压呼气治疗儿童急性哮喘发作:随机对照试验
这项前瞻性随机对照试验纳入52名2-18岁中重度急性哮喘发作患儿,在急诊完成一线治疗后随机接受单次短时正压呼气(PEP)治疗或标准治疗。结果显示PEP组与标准组在肺部哮喘评分变化、需额外治疗、急诊停留时间和处置方面均无显著差异,PEP未改善临床严重度。
要点
- 单次短时PEP治疗未显著改善急诊急性哮喘患儿的肺部哮喘评分。
- PEP组与标准组在需额外治疗、急诊停留时间和处置上无显著差异。
- PEP组有3例出现轻微自限性副作用。
核心结论
- 在完成一线治疗后,单次短时PEP治疗不能改善急诊急性哮喘患儿的临床严重度。
研究设计与样本
- 前瞻性随机对照试验,纳入2014年12月至2016年6月就诊于三级学术儿科急诊的2-18岁中重度哮喘发作患儿。
- 完成初始沙丁胺醇/异丙托溴铵和糖皮质激素治疗后仍为中重度哮喘的患儿随机接受PEP治疗或标准治疗,共52例(PEP组26例,标准组26例)。
主要发现
- 需额外治疗、急诊停留时间和处置方面两组均无显著差异。
- PEP组有3例出现轻微自限性副作用。
临床怎么用
- 对于急诊完成一线治疗后的中重度急性哮喘患儿,单次短时PEP治疗不应作为常规推荐以改善临床严重度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the efficacy of brief, single administration of positive expiratory pressure (PEP) therapy in reducing clinical severity and need for additional second-line therapies and hospitalization in children presenting to the emergency department (ED) with acute asthma. STUDY DESIGN: This was a prospective randomized controlled trial of children 2-18 years of age presenting to a tertiary-care academic pediatric ED with moderate-to-severe asthma exacerbations from December 2014 to June 2016. Children who continued to have moderate asthma severity after completion of initial therapies (albuterol/ipratropium bromide and corticosteroids) were randomized to receive PEP therapy or standard of care. The primary outcome was change in pulmonary asthma score before and after intervention, as assessed by a blinded physician. Secondary outcomes included need for additional therapies, ED length of stay, and disposition. RESULTS: A total of 52 patients were randomized to receive either PEP (n?=?26) or standard therapy (n?=?26). Study groups were similar in demographics and baseline characteristics. There was no significant difference in primary outcome between groups with a mean change in Pulmonary Asthma Score of 0.92 (±1.2) in the PEP group and 0.40 (±1.2) in the standard group (P?=?.12). There also was no significant difference in need for additional therapies, ED length of stay, and disposition. Mild, self-resolving side effects were observed in 3 subjects receiving PEP therapy. CONCLUSION: Single, brief, administration of PEP therapy after completion of first-line therapies does not improve clinical severity in children presenting to the ED with acute asthma. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02494076.
引用
- Navanandan N, Federico M, Mistry RD, et al. Positive Expiratory Pressure for the Treatment of Acute Asthma Exacerbations: A Randomized Controlled Trial. J Pediatr. 2017. PMID: 28284473. doi:10.1016/j.jpeds.2017.02.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。